Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Sep 15, 2026; 18(9): 123745
Published online Sep 15, 2026. doi: 10.4251/wjgo.123745
Published online Sep 15, 2026. doi: 10.4251/wjgo.123745
Figure 2 EPZ020411 inhibits the migration and invasion of colorectal cancer cells in a concentration-dependent manner.
A and B: Transwell assays showing the effects of increasing concentrations of EPZ020411 on the migration and invasion of HCT116 (A) and CACO-2 (B) cells; C and D: Wound healing assays assessing the migratory ability of HCT116 (C) and CACO-2 (D) cells after EPZ020411 treatment. Data are presented as mean ± SD from three independent experiments (n = 3). Error bars represented the mean ± SEM. bP < 0.001.
- Citation: Chen YZ, Liu J, Wang YP, Du J, Ma JC, Jin GS. EPZ020411, a PRMT6 inhibitor, suppresses colorectal cancer cell proliferation, migration, and invasion through targeting the TGM2/MAPK axis. World J Gastrointest Oncol 2026; 18(9): 123745
- URL: https://www.wjgnet.com/1948-5204/full/v18/i9/123745.htm
- DOI: https://dx.doi.org/10.4251/wjgo.123745